BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sattler A, Schrezenmeier E, Weber UA, Potekhin A, Bachmann F, Straub-Hohenbleicher H, Budde K, Storz E, Proß V, Bergmann Y, Thole LM, Tizian C, Hölsken O, Diefenbach A, Schrezenmeier H, Jahrsdörfer B, Zemojtel T, Jechow K, Conrad C, Lukassen S, Stauch D, Lachmann N, Choi M, Halleck F, Kotsch K. Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients. J Clin Invest 2021;131:150175. [PMID: 34101623 DOI: 10.1172/JCI150175] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Chang KM, Berlinrut I, Wallach FR. A case of severe COVID-19 despite full vaccination with mRNA-1273 SARS-CoV-2 vaccine (Moderna) in a kidney transplant recipient. Transpl Infect Dis 2021;:e13710. [PMID: 34339083 DOI: 10.1111/tid.13710] [Reference Citation Analysis]
2 Müller L, Andrée M, Ostermann PN, Jazmati N, Flüh G, Fischer JC, Bölke E, Heger E, Vanshylla K, Klein F, Wisplinghoff H, Schaal H, Drexler I, Walker A, Adams O, Timm J. SARS-CoV-2 Infection in Fully Vaccinated Individuals of Old Age Strongly Boosts the Humoral Immune Response. Front Med (Lausanne) 2021;8:746644. [PMID: 34708057 DOI: 10.3389/fmed.2021.746644] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mehrabi Nejad M, Moosaie F, Dehghanbanadaki H, Haji Ghadery A, Shabani M, Tabary M, Aryannejad A, Seyedalinaghi S, Rezaei N. Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis. Eur J Med Res 2022;27. [DOI: 10.1186/s40001-022-00648-5] [Reference Citation Analysis]
4 Benning L, Morath C, Bartenschlager M, Nusshag C, Kälble F, Buylaert M, Schaier M, Beimler J, Klein K, Grenz J, Reichel P, Hidmark A, Ponath G, Töllner M, Reineke M, Rieger S, Tönshoff B, Schnitzler P, Zeier M, Süsal C, Bartenschlager R, Speer C. Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 Vaccination. Clin J Am Soc Nephrol 2021:CJN. [PMID: 34937771 DOI: 10.2215/CJN.11820921] [Reference Citation Analysis]
5 Chandran S, Stock PG. COVID-19 Vaccination in Kidney Transplant Recipients: An Ounce Pre-Transplant is Worth a Pound Post-Transplant. JASN 2021;32:2977-8. [DOI: 10.1681/asn.2021101347] [Reference Citation Analysis]
6 Yahav D, Rozen-Zvi B, Mashraki T, Atamna A, Ben-Zvi H, Bar-Haim E, Rahamimov R. Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study). BMJ Open 2021;11:e055611. [PMID: 34635537 DOI: 10.1136/bmjopen-2021-055611] [Reference Citation Analysis]
7 Haase M, Lesny P, Haase-Fielitz A, Anderson M, Cloherty G, Stec M, Lucas C, Santos-Araujo C, Haarhaus M, Macario F. Immunogenicity and tolerability of COVID-19 vaccination in peritoneal dialysis patients-A prospective observational cohort study. Semin Dial 2021. [PMID: 34854131 DOI: 10.1111/sdi.13043] [Reference Citation Analysis]
8 Marra AR, Kobayashi T, Suzuki H, Alsuhaibani M, Tofaneto BM, Bariani LM, Auler MA, Salinas JL, Edmond MB, Doll M, Kutner JM, Pinho JRR, Rizzo LV, Miraglia JL, Schweizer ML. Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis. J Infect 2022:S0163-4453(21)00658-7. [PMID: 34982962 DOI: 10.1016/j.jinf.2021.12.035] [Reference Citation Analysis]
9 Nimmo A, Gardiner D, Ushiro-lumb I, Ravanan R, Forsythe JLR. The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic. Transplantation 2022;Publish Ahead of Print. [DOI: 10.1097/tp.0000000000004151] [Reference Citation Analysis]
10 Melin J, Svensson MK, Albinsson B, Winqvist O, Pauksens K. Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients. BMC Immunol 2021;22:70. [PMID: 34666683 DOI: 10.1186/s12865-021-00458-0] [Reference Citation Analysis]
11 Yamada M, Matsumoto E, Thomas CP, Carlson JR, Klutts JS, Kumar B, Streit JA, Swee ML. Case Report: Severe COVID-19 in a Kidney Transplant Recipient Without Humoral Response to SARS-CoV-2 mRNA Vaccine Series. Transplant Direct 2021;7:e743. [PMID: 34386580 DOI: 10.1097/TXD.0000000000001193] [Reference Citation Analysis]
12 Galmiche S, Luong Nguyen LB, Tartour E, de Lamballerie X, Wittkop L, Loubet P, Launay O. Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review. Clin Microbiol Infect 2021:S1198-743X(21)00566-8. [PMID: 35020589 DOI: 10.1016/j.cmi.2021.09.036] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kute V, Meshram HS, Sharma A, Chaudhury AR, Sudhindran S, Gokhale AK, Hote M, Guleria R, Rana DS, Prakash J, Ramesh V. Update on Coronavirus 2019 Vaccine Guidelines for Transplant Recipients. Transplant Proc 2021:S0041-1345(21)00683-7. [PMID: 34690000 DOI: 10.1016/j.transproceed.2021.09.007] [Reference Citation Analysis]
14 Giannella M, Righi E, Pascale R, Rinaldi M, Caroccia N, Gamberini C, Palacios-baena ZR, Caponcello G, Morelli MC, Tamè M, Busutti M, Comai G, Potena L, Salvaterra E, Feltrin G, Cillo U, Gerosa G, Cananzi M, Piano S, Benetti E, Burra P, Loy M, Furian L, Zaza G, Onorati F, Carraro A, Gastaldon F, Nordio M, Kumar-singh S, Abedini M, Boffetta P, Rodríguez-baño J, Lazzarotto T, Viale P, Tacconelli E; on behalf of The ORCHESTRA Study Group Workpackage. Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort. Microorganisms 2022;10:1021. [DOI: 10.3390/microorganisms10051021] [Reference Citation Analysis]
15 Füessl L, Lau T, Lean I, Hasmann S, Riedl B, Arend FM, Sorodoc-otto J, Soreth-rieke D, Toepfer M, Rau S, Salihi-halimi H, Paal M, Beuthien W, Thaller N, Suttmann Y, von Gersdorff G, Regenauer R, von Bergwelt-baildon A, Teupser D, Bruegel M, Fischereder M, Schönermarck U. Diminished Short- and Long-Term Antibody Response after SARS-CoV-2 Vaccination in Hemodialysis Patients. Vaccines 2022;10:605. [DOI: 10.3390/vaccines10040605] [Reference Citation Analysis]
16 Karakizlis H, Nahrgang C, Strecker K, Chen J, Aly M, Slanina H, Schüttler CG, Esso I, Wolter M, Todorova D, Jessen S, Adamik A, Ronco C, Seeger W, Weimer R, Sester M, Birk H, Husain-syed F. Immunogenicity and reactogenicity of homologous mRNA-based and vector-based SARS-CoV-2 vaccine regimens in patients receiving maintenance dialysis. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.108961] [Reference Citation Analysis]
17 Weigert A, Bergman ML, Gonçalves LA, Godinho I, Duarte N, Abrantes R, Borges P, Brennand A, Malheiro V, Matoso P, Akpogheneta O, Kosack L, Cruz P, Nogueira E, Pereira M, Ferreira A, Marques M, Nunes T, Faro-Viana J, Demengeot J, Penha-Gonçalves C. Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-Up. Front Med (Lausanne) 2021;8:796676. [PMID: 35004771 DOI: 10.3389/fmed.2021.796676] [Reference Citation Analysis]
18 Charmetant X, Espi M, Benotmane I, Barateau V, Heibel F, Buron F, Gautier-Vargas G, Delafosse M, Perrin P, Koenig A, Cognard N, Levi C, Gallais F, Manière L, Rossolillo P, Soulier E, Pierre F, Ovize A, Morelon E, Defrance T, Fafi-Kremer S, Caillard S, Thaunat O. Infection or a third dose of mRNA vaccine elicit neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients. Sci Transl Med 2022;:eabl6141. [PMID: 35103481 DOI: 10.1126/scitranslmed.abl6141] [Reference Citation Analysis]
19 Yanis A, Haddadin Z, Spieker AJ, Waqfi D, Rankin DA, Talj R, Thomas L, Birdwell KA, Ezzell L, Blair M, Eason J, Varjabedian R, Warren CM, Nochowicz CH, Olson EC, Simmons JD, Yoder S, Guy M, Thomsen I, Chappell JD, Kalams SA, Halasa NB. Humoral and cellular immune responses to the SARS-CoV-2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls. Transpl Infect Dis 2021;:e13772. [PMID: 34905653 DOI: 10.1111/tid.13772] [Reference Citation Analysis]
20 Gavriilaki E, Papadopoulou A, Touloumenidou T, Stavridou F, Koravou EE, Giannaki M, Papalexandri A, Karavalakis G, Batsis I, Kourelis A, Chatzopoulou F, Chatzidimitriou D, Sotiropoulos D, Yannaki E, Sakellari I, Anagnostopoulos A. Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients. Bone Marrow Transplant 2022. [PMID: 35449455 DOI: 10.1038/s41409-022-01675-w] [Reference Citation Analysis]
21 Peluso MJ, Donatelli J, Henrich TJ. Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions. Transl Res 2021:S1931-5244(21)00269-3. [PMID: 34780969 DOI: 10.1016/j.trsl.2021.11.006] [Reference Citation Analysis]
22 Paal M, Arend FM, Lau T, Hasmann S, Soreth-Rieke D, Sorodoc-Otto J, Beuthien W, Krappe J, Toepfer M, von Gersdorff G, Thaller N, Rau S, Northoff B, Teupser D, Bruegel M, Fischereder M, Schönermarck U. Antibody response to mRNA SARS-CoV-2 vaccines in haemodialysis patients. Clin Kidney J 2021;14:2234-8. [PMID: 34603700 DOI: 10.1093/ckj/sfab127] [Reference Citation Analysis]
23 Timmermann L, Globke B, Lurje G, Schmelzle M, Schöning W, Öllinger R, Pratschke J, Eberspächer B, Drosten C, Hofmann J, Eurich D. Humoral Immune Response following SARS-CoV-2 Vaccination in Liver Transplant Recipients. Vaccines (Basel) 2021;9:1422. [PMID: 34960168 DOI: 10.3390/vaccines9121422] [Reference Citation Analysis]
24 Karaba AH, Zhu X, Liang T, Wang KH, Rittenhouse AG, Akinde O, Eby Y, Ruff JE, Blankson JN, Abedon AT, Alejo JL, Cox AL, Bailey JR, Thompson EA, Klein SL, Warren DS, Garonzik-Wang JM, Boyarsky BJ, Sitaras I, Pekosz A, Segev DL, Tobian AAR, Werbel WA. A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant Recipients. medRxiv 2021:2021. [PMID: 34671774 DOI: 10.1101/2021.08.11.21261914] [Reference Citation Analysis]
25 Filippidis P, Vionnet J, Manuel O, Mombelli M. Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review. Expert Rev Anti Infect Ther 2021;:1-18. [PMID: 34854329 DOI: 10.1080/14787210.2022.2013808] [Reference Citation Analysis]
26 Fernandes Q, Inchakalody VP, Merhi M, Mestiri S, Taib N, Moustafa Abo El-Ella D, Bedhiafi T, Raza A, Al-Zaidan L, Mohsen MO, Yousuf Al-Nesf MA, Hssain AA, Yassine HM, Bachmann MF, Uddin S, Dermime S. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann Med 2022;54:524-40. [PMID: 35132910 DOI: 10.1080/07853890.2022.2031274] [Reference Citation Analysis]
27 Stock PG, Henrich TJ, Segev DL, Werbel WA. Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients. J Clin Invest 2021;131:151178. [PMID: 34143755 DOI: 10.1172/JCI151178] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Mamez AC, Pradier A, Giannotti F, Petitpas A, Urdiola MF, Vu DL, Masouridi-Levrat S, Morin S, Dantin C, Clerc-Renaud D, Eberhardt CS, Kaiser L, Simonetta F, Chalandon Y. Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2021. [PMID: 34584239 DOI: 10.1038/s41409-021-01466-9] [Reference Citation Analysis]
29 D'Amelio R, Asero R, Cassatella MA, Laganà B, Lunardi C, Migliorini P, Nisini R, Parronchi P, Quinti I, Racanelli V, Senna G, Vacca A, Maggi E. Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies. Biomedicines 2021;9:1163. [PMID: 34572349 DOI: 10.3390/biomedicines9091163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Grupper A, Katchman H. SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00359-0] [Reference Citation Analysis]
31 Manothummetha K, Chuleerarux N, Sanguankeo A, Kates OS, Hirankarn N, Thongkam A, Dioverti-Prono MV, Torvorapanit P, Langsiri N, Worasilchai N, Moonla C, Plongla R, Garneau WM, Chindamporn A, Nissaisorakarn P, Thaniyavarn T, Nematollahi S, Permpalung N. Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis. JAMA Netw Open 2022;5:e226822. [PMID: 35412626 DOI: 10.1001/jamanetworkopen.2022.6822] [Reference Citation Analysis]
32 Granata S, Carratù P, Stallone G, Zaza G. mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis. Front Pharmacol 2021;12:710543. [PMID: 34497515 DOI: 10.3389/fphar.2021.710543] [Reference Citation Analysis]
33 Carr EJ, Kronbichler A, Graham-Brown M, Abra G, Argyropoulos C, Harper L, Lerma EV, Suri RS, Topf J, Willicombe M, Hiremath S. Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD. Kidney Int Rep 2021;6:2292-304. [PMID: 34250319 DOI: 10.1016/j.ekir.2021.06.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Aslam S, Danziger-Isakov L, Mehra MR. COVID-19 vaccination immune paresis in heart and lung transplantation. J Heart Lung Transplant 2021;40:763-6. [PMID: 34144891 DOI: 10.1016/j.healun.2021.04.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Schrezenmeier E, Rincon-Arevalo H, Stefanski AL, Potekhin A, Staub-Hohenbleicher H, Choi M, Bachmann F, Pross V, Hammett C, Schrezenmeier H, Ludwig C, Jahrsdörfer B, Lino A, Eckardt KU, Kotsch K, Döerner T, Budde K, Sattler A, Halleck F. B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients. J Am Soc Nephrol 2021:ASN. [PMID: 34667083 DOI: 10.1681/ASN.2021070966] [Reference Citation Analysis]
36 Jahrsdörfer B, Fabricius D, Scholz J, Ludwig C, Grempels A, Lotfi R, Körper S, Adler G, Schrezenmeier H. BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Elderly Convalescents. Front Immunol 2021;12:743422. [PMID: 34659239 DOI: 10.3389/fimmu.2021.743422] [Reference Citation Analysis]
37 Lee ARYB, Wong SY, Chai LYA, Lee SC, Lee MX, Muthiah MD, Tay SH, Teo CB, Tan BKJ, Chan YH, Sundar R, Soon YY. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ 2022;376:e068632. [PMID: 35236664 DOI: 10.1136/bmj-2021-068632] [Reference Citation Analysis]
38 Moreno NF, Mcadams R, Goss JA, Galvan NTN. COVID-19 Vaccine Efficacy and Immunogenicity in End-Stage Renal Disease Patients and Kidney Transplant Recipients. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00366-1] [Reference Citation Analysis]
39 Benning L, Töllner M, Hidmark A, Schaier M, Nusshag C, Kälble F, Reichel P, Buylaert M, Grenz J, Ponath G, Klein K, Zeier M, Süsal C, Schnitzler P, Morath C, Speer C. Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers. Vaccines (Basel) 2021;9:857. [PMID: 34451982 DOI: 10.3390/vaccines9080857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Chen JJ, Lee TH, Tian YC, Lee CC, Fan PC, Chang CH. Immunogenicity Rates After SARS-CoV-2 Vaccination in People With End-stage Kidney Disease: A Systematic Review and Meta-analysis. JAMA Netw Open 2021;4:e2131749. [PMID: 34709385 DOI: 10.1001/jamanetworkopen.2021.31749] [Reference Citation Analysis]
41 Beeraka NM, Sukocheva OA, Lukina E, Liu J, Fan R. Development of antibody resistance in emerging mutant strains of SARS CoV-2: Impediment for COVID-19 vaccines. Rev Med Virol 2022;:e2346. [PMID: 35416390 DOI: 10.1002/rmv.2346] [Reference Citation Analysis]
42 Reindl-Schwaighofer R, Heinzel A, Mayrdorfer M, Jabbour R, Hofbauer TM, Merrelaar A, Eder M, Regele F, Doberer K, Spechtl P, Aschauer C, Koblischke M, Paschen C, Eskandary F, Hu K, Öhler B, Bhandal A, Kleibenböck S, Jagoditsch RI, Reiskopf B, Heger F, Bond G, Böhmig GA, Strassl R, Weseslindtner L, Indra A, Aberle JH, Binder M, Oberbauer R. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial. JAMA Intern Med 2021. [PMID: 34928302 DOI: 10.1001/jamainternmed.2021.7372] [Reference Citation Analysis]
43 Dekervel M, Henry N, Torreggiani M, Pouteau LM, Imiela JP, Mellaza C, Garnier AS, Dujardin A, Asfar M, Ducancelle A, Paquin A, Blanchi S, Besson V, Piccoli GB, Augusto JF. Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis. Clin Kidney J 2021;14:2349-55. [PMID: 34754430 DOI: 10.1093/ckj/sfab152] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
44 Hallett AM, Greenberg RS, Boyarsky BJ, Shah PD, Ou MT, Teles AT, Krach MR, López JI, Werbel WA, Avery RK, Bae S, Tobian AA, Massie AB, Higgins RSD, Garonzik-Wang JM, Segev DL, Bush EL. SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients. J Heart Lung Transplant 2021:S1053-2498(21)02445-1. [PMID: 34456108 DOI: 10.1016/j.healun.2021.07.026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Abu-Khader A, Wang W, Berka M, Galaszkiewicz I, Khan F, Berka N. SARS Cov-2 vaccination induces de novo donor-specific HLA antibodies in a renal transplant patient on waiting list: A case report. HLA 2021. [PMID: 34791833 DOI: 10.1111/tan.14492] [Reference Citation Analysis]
46 El Karoui K, De Vriese AS. COVID-19 in dialysis: clinical impact, immune response, prevention and treatment. Kidney International 2022. [DOI: 10.1016/j.kint.2022.01.022] [Reference Citation Analysis]
47 Reischig T, Kacer M, Vlas T, Drenko P, Kielberger L, Machova J, Topolcan O, Kucera R, Kormunda S. Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic. Am J Transplant 2021. [PMID: 34860470 DOI: 10.1111/ajt.16902] [Reference Citation Analysis]